• Posted: February 17, 2015 Personalization of cancer treatment using predictive simulation.

    Doudican NA, Kumar A, Singh N, Nair PR, Lala DA, Basu K, Talawdekar AA, Sultana Z, Tiwari K, Tyagi A, Abbasi T, Vali S, Vij R, Fiala M, King J, Perle M,...

    READ MORE
  • Posted: February 17, 2015 Renal insufficiency retains adverse prognostic implications despite renal...

    Khan R, Apewokin S, Grazziutti M, Yaccoby S, Epstein J, van Rhee F, Rosenthal A, Waheed S, Usmani S, Atrash S, Kumar S, Hoering A, Crowley J, Shaughnessy JD,...

    READ MORE
  • Posted: February 17, 2015 The addition of dexamethasone to bortezomib for patients with relapsed multiple...

    Harrison SJ, Quach H, Link E, Feng H, Dean J, Copeman M, Van De Velde H, Schwarer A, Baker B, Spencer A, Catalano J, Campbell P, Augustson B, Romeril K, Prince...

    READ MORE
  • Posted: February 17, 2015 Special Valentine’s Day’s Thank You For Our Caregivers

    With Valentine’s Day being the theme of February, the MMRF staff and I thought the timing was right to spotlight caregivers and the invaluable role they play...

    READ MORE
  • Posted: February 5, 2015 Obama’s push for a huge genetic biobank, and what it means for your health

    Critics may call this “needle in a haystack” discovery work much too speculative, but developing a 1 million-plus patient repository of genetic information...

    READ MORE
  • Posted: January 30, 2015 Take back control of your life in 2015

    Happy New Year! January should be a hopeful year in the world of multiple myeloma. Thanks to the MMRF and an international cadre of scientists and specialists,...

    READ MORE
  • Posted: January 27, 2015 Resolve To Get Involved!

    It’s January 2015, and that means the MMRF Events team has a new calendar of activities to participate in to raise money for multiple myeloma research!...

    READ MORE
  • Posted: January 23, 2015 A Re-Birthday Wish

    Every multiple myeloma patient who has been through a stem cell transplant remembers their new birthday, the day their donor’s precious cells are given to...

    READ MORE
  • Posted: January 22, 2015 Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the...

    Reece DE, Masih-Khan E, Atenafu EG, Jimenez-Zepeda VH, Anglin P, Chen C, Kukreti V, Mikhael JR, Trudel S. Br J Haematol.

    READ MORE
  • Posted: January 22, 2015 A phase 2, randomized, double-blind, placebo-controlled study of siltuximab...

    Orlowski RZ, Gercheva L, Williams C, Sutherland H, Robak T, Masszi T, Goranova-Marinova V, Dimopoulos MA, Cavenagh JD, Špička I, Maiolino A, Suvorov A,...

    READ MORE

Page 23/15